Multi-centre, randomised, double-blind, placebo-controlled trial of additive duloxetine for cancer-related neuropathic pain refractory to opioids and gabapentinoidsHiromichi Matsuoka,Satoru Iwase,Tempei Miyaji,Takashi Kawaguchi,Keisuke Ariyoshi,Shunsuke Oyamada,Eriko Satomi,Hiroto Ishiki,Hideaki Hasuo,Hiroko Sakuma,Akihiro Tokoro,Toshiaki Shinomiya,Hiroyuki Otani,Yoichi Otake,Tsukuura Hiroaki,Yoshihisa Matsumoto,Yoshikazu Hasegawa,Yuki Kataoka,Masatomo Otsuka,Kiyohiro Sakai,Yoshinobu Matsuda,Tatsuya Morita,Atsuko Koyama,Takuhiro YamaguchiASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY（2018）引用 0|浏览28暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
